Document is current
Any future updates will be listed below
-
Authors
Ziegler, John
Hechtman, Jaclyn F.
Rana, Satshil
Ptashkin, Ryan N.
Jayakumaran, Gowtham
Middha, Sumit https://orcid.org/0000-0003-4135-6268
Chavan, Shweta S. https://orcid.org/0000-0001-9433-6936
Vanderbilt, Chad https://orcid.org/0000-0002-8114-0237
DeLair, Deborah
Casanova, Jacklyn https://orcid.org/0000-0002-3586-7048
Shia, Jinru https://orcid.org/0000-0002-4351-2511
DeGroat, Nicole
Benayed, Ryma
Ladanyi, Marc https://orcid.org/0000-0001-9055-7213
Berger, Michael F. https://orcid.org/0000-0003-3882-5000
Fuchs, Thomas J.
Brannon, A. Rose https://orcid.org/0000-0003-4610-0149
Zehir, Ahmet https://orcid.org/0000-0001-5406-4104
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
- License Information
-
More Information
Article History
Received: 29 January 2021
Accepted: 27 November 2024
First Online: 2 January 2025
Competing interests
: John Ziegler is an employee of MongoDB, New York. Jaclyn F. Hechtman is an employee of Caris Life Sciences and has received consulting fees from Pfizer. Ryan N. Ptashkin is an employee of Natera. Gowtham Jayakumaran is an employee of Guardant Health. Sumit Middha is an employee of Adaptimmune. Shweta S. Chavan is an employee of Repertoire Immune Medicines, Cambridge, MA. Chad Vanderbilt has equity, Intellectual Property Rights, Professional Services and Activities (uncompensated) for Paige.AI. Deborah DeLair is an employee of Northwell Health, Greenvale, NY. Jinru Shia has been engaged in Professional Services and Activities (uncompensated) for Paige.AI. Nicole DeGroat is an employee of Regeneron Pharmaceuticals, Tarrytown, NY. Ryma Benayed is an employee of AstraZeneca, New York. Marc Ladanyi received advisory board compensation from Merck, Bristol-Myers Squibb, Takeda, Bayer, Lilly Oncology, and Paige.AI, and research support from LOXO Oncology and Helsinn Healthcare. Michael F. Berger received consulting fees from Eli Lilly, AstraZeneca, and Paige.AI, grant support from Boundless Bio, and has intellectual property rights in SOPHiA Genetics. Thomas J. Fuchs is the founder, chief scientist, and shareholder of Paige.AI and is an employee of Elli Lilly and Company. A. Rose Brannon has intellectual property rights in SOPHiA Genetics. Ahmet Zehir is an employee of Natera and received honoraria from Illumina. The remaining authors declare no competing interests.
